| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4029199 | Ophthalmology | 2007 | 11 Pages |
Abstract
Bromfenac ophthalmic solution 0.09% effectively and rapidly cleared ocular inflammation and reduced ocular pain after CE. There were no serious ocular adverse events, and fewer adverse events were reported for the bromfenac group.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Eric D. MD, FACS, Edward J. MD, Robert H. MD, FACS, James A. BSc (Med), MD, Lisa R. PhD, Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group,